FSR FISKER INC. INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation into Fisker Inc. (NYSE: FSR) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
Newtown, PA, November 9, 2023 – Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Fisker Inc. (NYSE: FSR) and whether its senior officers disseminated false and misleading statements and/or failed to disclose material information to investors (the “Fisker Investigation”). On November 8, 2023, Fisker shocked the market when it announced that it was delaying the release of its third-quarter financials.
If you have non-public information that could assist in the Fisker Investigation or if you are a Fisker investor who suffered a loss and would like to learn more, you can provide your information HERE.
THE COMPANY: Fisker Inc. is focused on designing and developing electric vehicles.
THE ALLEGED WRONGDOING: The company has delayed the release of its third quarter 2023 financial results for nearly three weeks due to the abrupt resignation and replacement of its chief accounting officer.
THE REVELATION: On November 8, 2023, Fisker issued a statement saying: “The timing of the appointment of a new chief accounting officer effective Nov. 6, 2023, and the departure of the former chief accounting officer effective Oct. 27, 2023, has delayed the completion of the financial statements and related disclosures.” On this news the price of Fisker stock plummeted 7.2% in midday trading, to drop below its November 1 record-low closing price of $4.14 per share.
About Edelson Lechtzin LLP: Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving securities and investment fraud, our lawyers focus on class and collective litigation in cases alleging violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and dangerous and defective drugs and medical devices.
For more information, please contact:
Marc H. Edelson, Esq.
Eric Lechtzin, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-563-5550 or 215-867-2399
Email: [email protected] or [email protected]
This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. Your ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.